Cited by 25Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchPancreatic function and diabetes

Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study

Open access
Oram, Richard A, Rawlingson, Andrew, Shields, Beverley M, Bingham, Coralie, Besser, Rachel E J, McDonald, Tim J, Knight, Bridget A, Hattersley, Andrew T·2013·BMJ Open

Abstract

Objectives: The current assessment of insulin resistance (IR) in epidemiology studies relies on the blood measurement of C-peptide or insulin. A urine C-peptide creatinine ratio (UCPCR) can be posted from home unaided. It is validated against serum measures of the insulin in people with diabetes. We tested whether UCPCR could be a surrogate measure of IR by examining the correlation of UCPCR with serum insulin, C-peptide and HOMA2 (Homeostasis Model Assessment 2)-IR in participants without diabetes and with chronic kidney disease (CKD). Design: Observational study. Setting: Single-centre clinical research facility. Participants: 37 healthy volunteers and 30 patients with CKD (glomerular filtration rate 15–60) were recruited. Primary and secondary endpoints: Serum insulin, C-peptide and glucose at fasting (0), 30, 60, 90 and 120 min were measured during an oral glucose tolerance test (OGTT). Second-void fasting UCPCR and 120 min post-OGTT UCPCR were collected. HOMA2-IR was calculated using fasting insulin and glucose. The associations between UCPCR and serum measures were assessed using Spearman's correlations. Results: In healthy volunteers, fasting second-void UCPCR strongly correlated with serum insulin (r s =0.69, p<0.0001), C-peptide (r s =0.73, p<0.0001) and HOMA2-IR (r s =−0.69, p<0.0001). 120 min post-OGTT UCPCR correlated strongly with C-peptide and insulin area under the curve. In patients with CKD, UCPCR did not correlate with serum C-peptide, insulin or HOMA2-IR. Conclusions: In participants with normal renal function, UCPCR may be a simple, practical method for the assessment of IR in epidemiology studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2013-003193

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [17]WHO Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus, abbreviated report of a WHO consultation. 2011 http://www.who.int/diabetes/publications/report-hba1c_2011.pdf 26158184

Cited by

Sorted by citations

Authors
Oram, R. A., Rawlingson, A., Shields, B. M., Bingham, C., Besser, R. E. J., McDonald, T. J., Knight, B. A., & Hattersley, A. T.
Affiliations
  • University of Exeter (GB)
  • Royal Devon & Exeter NHS Foundation Trust (GB)
  • NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK
Corresponding author
Oram, Richard A
Venue
BMJ Open
Publisher
BMJ
Published
2013-12
Volume
3
Issue
12
Pages
e003193
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2134197986
Cited by
25
References
17
Citations by year
2026: 3 · 2025: 1 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2014: 2
FWCI
1.05
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMJ Open (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion)
  • Open Research Exeter (University of Exeter) (submittedVersion, cc-by)
  • Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
Funders
  • Wellcome Trust (067463)
  • National Institute for Health and Care Research (NF-SI-0611-10219)
  • Diabetes UK (11/0004171)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
insulin resistance, insulin secretion, C-peptide, HOMA2-IR, chronic kidney disease, oral glucose tolerance test, non-invasive biomarkers, healthy volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review